D
DaVita Clinical Research | Las Vegas, NV
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
BI 685509
KBP-5074
VX-147
Atrasentan
LNP023
Parent organization
This site is a part of DaVita Clinical Research
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 6 total trials
The purpose of this study is to evaluate the long-term safety and tolerability, of open label iptacopan in primary IgA nephropathy participants who h...
Enrolling
Primary IgA Nephropathy
Drug: LNP023
The AFFINITY Study is a phase 2, open-label, basket study to evaluate the efficacy and safety of atrasentan in patients with proteinuric glomerular d...
Active, not recruiting
Immunoglobulin A Nephropathy
Alport Syndrome
Drug: Atrasentan
The purpose of this study is to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants...
Enrolling
Proteinuric Kidney Disease
Drug: Placebo
Drug: VX-147
Trial sponsors
C
K
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems